David Bredt - Feb 3, 2025 Form 4 Insider Report for Rapport Therapeutics, Inc. (RAPP)

Role
Chief Scientific Officer
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
RAPP
Transactions as of
Feb 3, 2025
Transactions value $
$0
Form type
4
Date filed
2/4/2025, 05:30 PM
Previous filing
Jun 6, 2024
Next filing
Mar 17, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RAPP Stock Option (Right to Buy) Award $0 +100K $0.00 100K Feb 3, 2025 Common Stock 100K $16.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 1, 2025, subject to the Reporting Person's continued service on each such vesting date.